We are live on ! Find out more
Man Group

Man Group Portfolio holdings

AUM $55.1B
1-Year Est. Return 24.23%
This Fund
S&P 500
This Quarter Est. Return
+2.61%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
AUM
$39.6B
AUM Growth
-$67.3M
Cap. Flow
-$1.56B
Cap. Flow %
-3.93%
Top 10 Hldgs %
14.94%
Holding
2,343
New
235
Increased
870
Reduced
773
Closed
343

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$343M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$144M
3
DT icon
Dynatrace
DT
+$135M
4
NDAQ icon
Nasdaq
NDAQ
+$129M
5
BKNG icon
Booking.com
BKNG
+$125M

Sector Composition

Rank Sector Weight
1 Technology 23.36%
2 Consumer Discretionary 12.08%
3 Healthcare 11.86%
4 Financials 10.83%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMHC icon
326
Taylor Morrison
TMHC
$6.67B
$27.2M 0.07%
489,959
-50,619
-9% -$2.89M
GPC icon
327
Genuine Parts
GPC
$17.1B
$27M 0.07%
195,476
+139,135
+247% +$20.8M
NCLH icon
328
Norwegian Cruise Line
NCLH
$8.89B
$27M 0.07%
1,438,029
+1,359,178
+1,724% +$23.9M
CORT icon
329
Corcept Therapeutics
CORT
$10.2B
$27M 0.07%
829,943
-668,977
-45% -$18.3M
CTVA icon
330
Corteva
CTVA
$59.7B
$27M 0.07%
499,740
+98,837
+25% +$5.44M
PEP icon
331
PepsiCo
PEP
$186B
$26.9M 0.07%
162,975
-184,888
-53% -$31.9M
DGX icon
332
Quest Diagnostics
DGX
$25.1B
$26.8M 0.07%
196,076
+15,978
+9% +$2.19M
EMR icon
333
Emerson Electric
EMR
$82.9B
$26.8M 0.07%
243,200
-123,538
-34% -$13.7M
RPRX icon
334
Royalty Pharma
RPRX
$26.1B
$26.6M 0.07%
1,010,468
+813,343
+413% +$22.5M
AA icon
335
Alcoa
AA
$11.7B
$26.6M 0.07%
669,313
+262,496
+65% +$10.2M
ROKU icon
336
Roku
ROKU
$21.1B
$26.6M 0.07%
444,047
+388,832
+704% +$22.8M
PPC icon
337
Pilgrim's Pride
PPC
$6.82B
$26.6M 0.07%
690,646
+569,678
+471% +$20.5M
ICLR icon
338
Icon
ICLR
$12.8B
$26.4M 0.07%
84,214
+44,209
+111% +$13.9M
OKTA icon
339
Okta
OKTA
$24.1B
$26.3M 0.07%
280,809
+159,996
+132% +$15.1M
MOH icon
340
Molina Healthcare
MOH
$10.3B
$26.3M 0.07%
88,416
+67,876
+330% +$23M
KNSL icon
341
Kinsale Capital Group
KNSL
$8.05B
$26.2M 0.07%
67,931
+1,850
+3% +$751K
KBH icon
342
KB Home
KBH
$3.48B
$26.1M 0.07%
371,204
-18,917
-5% -$1.29M
POST icon
343
Post Holdings
POST
$4.12B
$26M 0.07%
249,605
-91,608
-27% -$9.54M
PRFT
344
DELISTED
Perficient Inc
PRFT
$26M 0.07%
347,478
+333,834
+2,447% +$21.3M
DV icon
345
DoubleVerify
DV
$1.62B
$26M 0.07%
1,333,990
+1,262,691
+1,771% +$30.5M
RARE icon
346
Ultragenyx Pharmaceutical
RARE
$2.65B
$25.8M 0.07%
628,726
+475,085
+309% +$20.3M
ITUB icon
347
Itaú Unibanco
ITUB
$91.3B
$25.8M 0.07%
5,009,437
+2,381,697
+91% +$13M
LLY icon
348
PUT
Eli Lilly
LLY
$1.07T
$25.8M 0.07%
28,500
+11,400
+67% +$9.12M
HXL icon
349
Hexcel
HXL
$8.32B
$25.4M 0.06%
405,943
+224,569
+124% +$15.1M
LLY icon
350
CALL
Eli Lilly
LLY
$1.07T
$25.4M 0.06%
28,000
+11,400
+69% +$9.12M

Similar funds

Man Group's Q2 2024 Portfolio in Review

As of Q2 2024, Man Group held 2,343 positions worth $39.6B, down 0.17% from $39.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Man Group withdrew a net $1.56B in Q2 2024, closing 343 positions and reducing 773 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $92.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Man Group opened a new position in Masimo worth $36.7M.

  • Man Group's largest Q2 2024 buy was Masimo: 291,789 shares worth $36.7M.
  • Man Group added most to CRH in Q2 2024, an estimated $199M increase.
  • Man Group's biggest Q2 2024 reduction was TSMC, cutting an estimated $343M.
  • Man Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $92.5M.
  • Man Group's ten largest holdings make up 15% of its $39.6B portfolio in Q2 2024.
  • Man Group opened 235 new positions and closed 343 in Q2 2024.
  • Man Group's portfolio value fell 0.17% quarter-over-quarter to $39.6B.

Based on Man Group's 13F filing for Q2 2024, filed 14 Aug 2024.